Dossier DOS-002
Dossier in NeeS format, version 6.8.9, for application EMA-2023-0002. The module tree below shows the 5 CTD modules with their component count and status.
Dossier ID
DOS-002
Format
NeeS
Version
6.8.9
Status
Approved
Application
Created
2022-10-08
Updated
2023-03-20
Total Modules
5
Module Tree
| Module | Title | Components | Status |
|---|---|---|---|
| 1 | Administrative Information and Prescribing Information | 14 | Completed |
| 2 | CTD Summaries | 4 | Pending |
| 3 | Quality | 13 | In Progress |
| 4 | Nonclinical Study Reports | 4 | Overdue |
| 5 | Clinical Study Reports | 7 | In Progress |
Content Components (showing first 20)
| ID | Section | Title | Version | Format | Words | Status | Owner |
|---|---|---|---|---|---|---|---|
| CC-002 | 3.5.5 | Drug Product | 9.3 | Word | 12,430 | Blocked | Tomoko Ikeda |
| CC-102 | 4.1.8 | Pharmacokinetics Studies | 9.7 | 10,432 | In Progress | Lieselotte van der Berg | |
| CC-202 | 3.9.3 | Analytical Methods | 7.5 | XML | 736 | Failed | Lieselotte van der Berg |
| CC-302 | 5.1.5 | Study Reports – Clinical Pharmacology | 5.7 | Word | 5,482 | Draft | Priya Sharma |
| CC-402 | 1.7.6 | Proposed Conditions of Approval | 1.5 | XML | 4,389 | Submitted | Sarah Chen |
| CC-502 | 4.8.6 | Toxicology Studies | 5.9 | Word | 6,465 | Pending | Priya Sharma |
| CC-602 | 5.5.2 | Study Reports – Clinical Pharmacology | 5.2 | 3,279 | Approved | Priya Sharma | |
| CC-702 | 1.9.9 | Prescribing Information | 1.3 | XML | 3,109 | Approved | Aisha Okonkwo |
| CC-802 | 4.6.7 | Carcinogenicity | 1.8 | XML | 10,420 | Submitted | James O'Brien |
| CC-902 | 3.6.9 | Stability Data | 10.7 | Word | 1,634 | In Progress | Priya Sharma |
| CC-1002 | 5.8.8 | Integrated Summary of Safety | 5.9 | XML | 4,428 | Pending | Tomoko Ikeda |
| CC-1102 | 1.1.3 | Cover Letter | 3.7 | 13,372 | Overdue | Nadia Petrova | |
| CC-1202 | 3.9.4 | Container Closure System | 1.7 | HTML | 1,552 | Blocked | Aisha Okonkwo |
| CC-1302 | 2.6.8 | Quality Overall Summary | 6.7 | 1,438 | Overdue | Sarah Chen | |
| CC-1402 | 1.9.1 | Proposed Conditions of Approval | 7.0 | Word | 7,229 | Completed | James O'Brien |
| CC-1502 | 4.9.3 | Carcinogenicity | 10.5 | HTML | 1,284 | Active | Priya Sharma |
| CC-1602 | 3.2.1 | Manufacturing Process | 5.4 | XML | 4,929 | Active | Carlos Mendez |
| CC-1702 | 2.5.2 | Clinical Overview | 5.1 | 14,652 | Blocked | Priya Sharma | |
| CC-1802 | 4.4.5 | Toxicology Studies | 7.6 | HTML | 9,454 | Completed | Priya Sharma |
| CC-1902 | 5.2.9 | Integrated Summary of Safety | 6.3 | Word | 8,553 | Draft | Aisha Okonkwo |
Showing 20 of 20 components